Publicaciones internacionales

2025

María Poza, Alejandro Martin-Muñoz, Patricia López-Pereira, Gloria Figaredo, Irene Zamanillo, Rodrigo Íñiguez, Ana Carla Oliveira, Tycho Baumann, Antonia Rodríguez-Izquierdo, Carlos Grande, Pilar Sarandeses, Enrique Revilla, Montserrat Cortés, Rosa Ayala, María Calbacho, Joaquín Martínez, Santiago Barrio, Ana Jiménez-Ubieto. Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma. Cancers 202517(7), 1065; https://doi.org/10.3390/cancers17071065Ver articulo completo: Poza, M

 

Mariana Bastos-Oreiro, Gloria Iacoboni, Víctor N. Garcés, Ana C. Caballero, Nuria Martínez, Javier Delgado, Aitana Balaguer, Mi Kwon, Sonia Gonzalez de Villambrosia, Rafael Hernani, Ana Jimenez-Ubieto, Rebeca Bailen, Izaskun Zaberio, Alejandro Martín García-Sancho, Pere Barba. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 04 February 2025.https://doi.org/10.1002/hem3.70077. Ver articulo completo: Bastos, M

 

Aitana Avendaño Pomares, Laura Rodríguez Merino, Sonia González, Jordi Morata, Raúl Tonda, Patricia Arribas, José Revert, Estrella Carrillo, Carlos Grande, Josep Maria Roncero, Jaime Pérez de Oteyza, Concepción Nicolás, Norma Gutierrez; Pau Abrisqueta; Antonio Gutiérrez, Ángel Ramírez-Páyer, Alejandro Martin Garcia-Sancho, Eva González-Barca, Santiago Montes-Moreno. Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma. PlosOne. March 11, 2025. https://doi.org/10.1371/journal.pone.0318689. Ver articulo completo: Avendaño, A

 

Carmen Martínez, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Hervé Ghesquières, Luc-Mathieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, Burhan Ferhanoğlu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso de Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda. Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group.  Bone Marrow Transplantation, 15 April 2025. Ver articulo completo: Martinez, C

 

Leyre Bento, Antonio Gutiérrez, Carmen Martinez, María Consejo Ortí Verdet, Marina Sorribes Portella, Ana Carolina Caballero Gonzalez, Marta Peña, Ariadna Pérez, Ana Jiménez-Ubieto, Lucía Medina, Mariana Beatriz Bastos Oreiro, Paula Fernández Caldas-González, Maria Belen Navarro, Isabel Salcedo, Pau Abrisqueta, Ignacio Español, Javier Cornago Navascués, Fernando Martin-Moro, Lucía García Tomás, Pilar Gómez-Prieto, María Rosario Varela, María Puente, Joud Zanabili, Teresa Zudaire, Izaskun Zeberio, Raquel del Campo, Leslie González Pinedo, Pedro Antonio Gonzalez-Sierra, Cristina Blázquez-Goñi, Jordina Rovira, Marta Sitges, Mireia Franch-Sarto, Almudena Cabero Martínez, Alberto Mussetti, Juan Montoro, Antonia Sampol, Anna Sureda, Dolores Caballero-Barrigon, Alejandro Martin Martin Garcia-Sancho. Autologous Stem Cell Transplantation for Relapsed/Refractory Large B Cell Lymphoma: Multicenter GETH-TC/GELTAMO Study. Blood AdvancesMarch 31, 2025. https://doi.org/10.1182/bloodadvances.2024015415. Ver articulo completo: Bento, L

 

2024
2023
2022
2020
2021
2019
2017
2018
2016
2015
2014
2013
2011
2010
2008
2007
2005
2004
2003
2002
2001
1999
2000
1997
1998
1996
1994
1993
1992
1991
1995

Buscar